غربالگری بیماریها
Z13 · عمومی
این بسته یک پیشنهاد برای کادر درمان است، نه نسخه. دوز، مدت و مناسببودنِ هر قلم برای این بیمار خاص را پزشک تعیین میکند. ابزارآلات به پروندهی هیچ بیماری وصل نیست و چیزی ثبت نمیکند. خودسرانه دارو مصرف نکنید.
آزمایش5
پاراکلینیک3
منابعبازبینی بالینی نشده
این محتوا از دانش عمومی پزشکی نوشته شده و به منابع زیر پیوند دارد، ولی هنوز یک پزشک آن را بازبینی و امضا نکرده است. جای دستورالعمل رسمی را نمیگیرد.
USPSTFColorectal Cancer: ScreeningThe USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years. See the "Practice Considerations" section and Table 1 for details about screening strategies.
USPSTFBreast Cancer: ScreeningThe USPSTF recommends biennial screening mammography for women aged 40 to 74 years. †
USPSTFCervical Cancer: ScreeningThe USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. For women aged 30 to 65 years, the USPSTF recommends screening every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology (cotesting). See the Clinical Considerations section for the relative benefits and harms of alternative screening strategies for women 21 years or older.
USPSTFLung Cancer: ScreeningThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.
USPSTFHuman Immunodeficiency Virus (HIV) Infection: ScreeningThe USPSTF recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened. See the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.
شناسهی نسخهی محتوا: doctorjan base pack v1